163 related articles for article (PubMed ID: 31359388)
1. Ligand Design for Modulation of RXR Functions.
Martínez C; Souto JA; de Lera AR
Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
[TBL] [Abstract][Full Text] [Related]
2. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
Dominguez M; Alvarez S; de Lera AR
Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
[TBL] [Abstract][Full Text] [Related]
3. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
4. Natural ligands of RXR receptors.
García P; Lorenzo P; de Lera AR
Methods Enzymol; 2020; 637():209-234. PubMed ID: 32359646
[TBL] [Abstract][Full Text] [Related]
5. Advances in drug design with RXR modulators.
Vaz B; de Lera ÁR
Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251
[TBL] [Abstract][Full Text] [Related]
6. Retinoid X Receptor Selective Agonists and their Synthetic Methods.
Wagner CE; Jurutka PW; Marshall PA; Heck MC
Curr Top Med Chem; 2017; 17(6):742-767. PubMed ID: 27320333
[TBL] [Abstract][Full Text] [Related]
7. The multi-faceted role of retinoid X receptor in bone remodeling.
Menéndez-Gutiérrez MP; Ricote M
Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
[TBL] [Abstract][Full Text] [Related]
8. Retinoid X receptor ligands: a patent review (2007 - 2013).
Yamada S; Kakuta H
Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
[TBL] [Abstract][Full Text] [Related]
9. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.
Giner XC; Cotnoir-White D; Mader S; Lévesque D
FASEB J; 2015 Oct; 29(10):4256-67. PubMed ID: 26148973
[TBL] [Abstract][Full Text] [Related]
10. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.
Watanabe M; Fujihara M; Motoyama T; Kawasaki M; Yamada S; Takamura Y; Ito S; Makishima M; Nakano S; Kakuta H
J Med Chem; 2021 Jan; 64(1):430-439. PubMed ID: 33356247
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptors: common heterodimerization partners with distinct functions.
Lefebvre P; Benomar Y; Staels B
Trends Endocrinol Metab; 2010 Nov; 21(11):676-83. PubMed ID: 20674387
[TBL] [Abstract][Full Text] [Related]
13. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
[TBL] [Abstract][Full Text] [Related]
14. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
[TBL] [Abstract][Full Text] [Related]
15. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
[TBL] [Abstract][Full Text] [Related]
16. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
Wagner CE; Jurutka PW
Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
[TBL] [Abstract][Full Text] [Related]
17. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
Ahuja HS; Szanto A; Nagy L; Davies PJ
J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
[TBL] [Abstract][Full Text] [Related]
18. Alternative retinoid X receptor (RXR) ligands.
Krężel W; Rühl R; de Lera AR
Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
Schierle S; Merk D
Expert Opin Ther Pat; 2019 Aug; 29(8):605-621. PubMed ID: 31298602
[No Abstract] [Full Text] [Related]
20. Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.
Fujii S; Ohsawa F; Yamada S; Shinozaki R; Fukai R; Makishima M; Enomoto S; Tai A; Kakuta H
Bioorg Med Chem Lett; 2010 Sep; 20(17):5139-42. PubMed ID: 20656484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
